Tag: HP-MAP
Vaxxas’ needle-free seasonal influenza vaccine enters clinical trial
Vaxxas has commenced the Phase I clinical trial of the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate via its proprietary high-density microarray patch (HD-MAP) technology.
Featured Article
AVEVA and Schneider Electric spearhead digital transformation in mining
AVEVA, a global leader in industrial software driving digital transformation, has partnered with Schneider Electric to redefine what smart, sustainable mining looks like in the age of AI.
